Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Promising second generation vascular targeting agent

April 20, 2004

Gloucester Pharmaceuticals acquires license to FK-228

April 19, 2004

New phase I trial for VEGF Trap

April 19, 2004

CB-300945, a novel selective alpha-FR targeted thymidylate synthase inhibitor

April 19, 2004

Novacea provides evidence for the antitumor effects of DN-101 and AQ4N

April 19, 2004

Novel androgen receptor antagonist for advanced prostate cancer therapy designed by BMS

April 19, 2004

Small molecule inhibitor of hypoxia-inducible factor-1 identified

April 19, 2004

New phosphatase inhibitors active against hepatoma cells in vitro

April 19, 2004

Myriad Genetics licenses rights to new colon cancer gene MYH

April 16, 2004

SBIR grant supports Kosan's development of next-generation Hsp90 inhibitors

April 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...